Assessment of Molecular Relapse Detection in Early-Stage Breast Cancer

Importance

Current treatment cures most cases of early-stage, primary breast cancer. However, better techniques are required to identify which patients are at risk of relapse.

Objective

To assess the clinical validity of molecular relapse detection with circulating tumor DNA (ctDNA) analysis in early-stage breast cancer.

Design, Setting, and Participants

This prospective, multicenter, sample collection, validation...